Helius Therapeutics have announced the appointment of Frazer Murray as Chief Growth & Partnerships Officer

We are thrilled to share that Helius Therapeutics have announced the appointment of Frazer Murray to the Chief Growth and Partnerships Officer role following an extensive executive search by Baxter Executive Search.

Frazer brings over a decade of leadership experience in the medical technology and biotechnology sectors, having held senior roles at Novartis Pharmaceuticals and, most recently, Aroa Biosurgery, where he led global marketing and strategy.

He began his career as a veterinarian, practicing in New Zealand and the UK. This foundation in clinical practice and patient care fostered a lifelong passion for advancing healthcare outcomes and improving access to quality medicines.

Frazer will lead Helius’ commercial operations, strengthen its presence in New Zealand, and build strategic global partnerships to grow the reach of Helius’ cannabinoid therapeutics.

We congratulate Frazer and wish him every success with this impactful role.